Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury

Neuroscience

Volumn 158, Issue 2, 2009, Pages 732-744

  Ranasinghe, H S ^a,b   Williams, C E ^a,b,c   Christophidis, L J ^a   Mitchell, M D ^a,b   Fraser, M ^a,b   Scheepens, A ^a,b,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b National Research Centre for Growth and Development Auckland   (New Zealand)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

brain; cortex; MMP 2; MMP 9; preterm; protease

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; HEMISPHERE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROECTODERM; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; GAP-43 PROTEIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA-ISCHEMIA, BRAIN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PHOSPHOPYRUVATE HYDRATASE; PREGNANCY; RATS; RATS, WISTAR; TIME FACTORS;

EID: 58149477482     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.07.069     Document Type: Article

References (50)

1. Asahi M., Asahi K., Jung J., Zoppo G.D., Fini M., and Lo E. Role for matrix metalloproteinases 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20 (2000) 1681-1689
2. Asahi M., Wang X., Mori T., Sumii T., Jung J., Moskowitz M., Fini M., and Lo E. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21 (2001) 7724-7732
3. Ayoub A., Cai T., Kaplan R., and Luo J. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex. J Comp Neurol 481 (2005) 403-415
4. Beilharz E., Williams C., Dragunow M., Sirimanne E., and Gluckman P. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol Brain Res 29 (1995) 1-14
5. Blumenthal I. Periventricular leucomalacia: a review. Eur J Pediatr 163 (2004) 435-442
6. Bosman F., and Stamenkovic I. Function structure and composition of the extracellular matrix. J Pathol 200 (2003) 423-428
7. Clancy B., Darlington R.B., and Finlay B.L. Translating developmental time across mammalian species. Neuroscience 105 (2001) 7-17
8. Ferguson T., and Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16 (2000) 157-167
9. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., and Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842 (1999) 92-100
10. Gasche Y., Copin J., Sugawara T., Fujimura M., and Chan P. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21 (2001) 1393-1400
11. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
12. Gutiérrez-Fernández A., Inada M., Balbín M., Fueyo A., Pitiot A., Astudillo A., Hirose K., Hirata M., Shapiro S., Noël A., Werb Z., Krane S., López-Otín C., and Puente X. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 21 (2007) 2580-2591
13. Hamann G.F., Burggraf D., Martens H.K., Liebetrau M., Jager G., Wunderlich N., DeGeorgia M., and Krieger D.W. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke 35 (2004) 764-769
14. Hehr C., Hocking J., and McFarlane S. Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points. Development 132 (2005) 3371-3379
15. Hsu J., McKeon R., Goussev S., Werb Z., Lee J., Trivedi A., and Noble-Haeusslein L. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 26 (2006) 9841-9850
16. Jiang X., Namura S., and Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305 (2001) 41-44
17. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A., Diguardher T., Khrestchatisky M., and Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18 (2003) 1507-1517
18. Krekoski C., Neubauer D., Graham J., and Muir D. Metalloproteinse-dependent predegeneration in vitro enhances axonal regeneration within acellular peripheral nerve grafts. J Neurosci 22 (2002) 10408-10415
19. Lee S.-R., Tsuji K., Lee S.-R., and Lo E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24 (2004) 671-678
20. Meiri F., Saffell L., Walsh F., and Doherty P. Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. J Neurosci 18 (1998) 10429-10437
21. Meng S., Arai Y., Deguchi K., and Takashima S. Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev 19 (1997) 480-484
22. Murphy G., and Knauper V. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?. Matrix Biol 15 (1997) 511-518
23. Nagase H., and Woessner J. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
24. Ogier C., Bernard A., Chollet A., Diguardher T., Hanessian S., Charton G., Kherstchatisky M., and Rivera S. Matrix metalloproteinase-2 (MMP-2) regulated astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54 (2006) 272-284
25. Oh L., Larsen P., Krekoski C., Edwards D., Donovan F., Werb Z., and Yong V. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19 (1999) 8464-8475
26. Pfefferkorn T., and Rosenberg G.A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34 (2003) 2025-2030
27. Planas A., Sole S., and Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 8 (2001) 834-846
28. Planas A., Sole S., Justicia C., and Farre E. Estimation of gelatinase content in rat brain: effect of focal ischemia. Biochem Biophys Res Commun 278 (2000) 803-807
29. Rivera S., Ogier C., Jourquin J., Timsit S., Szklarczyk A., Miller K., Gearing A., Kaczmarek L., and Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 15 (2002) 19-32
30. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
31. Rosenberg G. Matrix metalloproteinases in neuroinflammation. GLIA 39 (2002) 279-291
32. Rosenberg G., Cunningham L., Wallace J., Alexander S., Estrada E., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893 (2001) 104-112
33. Rosenberg G., Navratil M., Barone F., and Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16 (1996) 360-366
34. Schulz C.G., Sawicki G., Lemke R.P., Roeten B.M., Schulz R., and Cheung P.-Y. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res 55 (2004) 794-801
35. Sethi C.S., Bailey T.A., Luthert P.J., and Chong N.H.V. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol 84 (2000) 654-666
36. Silver J., and Miller J. Regeneration beyond the glial scar. Nat Rev Neurosci 5 (2004) 146-156
37. Sirimanne E., Guan J., Williams C., and Gluckman P. Two models for determining the mechanisms of damage and repair after hypoxic-ischaemic injury in the developing rat brain. J Neurosci Methods 55 (1994) 7-14
38. Sizonenko S., Kiss J., Inder T., Gluckman P., and Williams C. Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr Res 57 (2005) 865-872
39. Skene J. Axonal growth-associated proteins. Annu Rev Neurosci 12 (1989) 127-156
40. Soler R., Gui Y., Linask K., and Muschel R. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Dev Brain Res 88 (1995) 37-52
41. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol (2003) 448-464
42. Svedin P., Hagberg H., Savman K., Zhu C., and Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 27 (2007) 1511-1518
43. Ulrich R., Gerhauser I., Seeliger F., Baumgartner W., and Alldinger S. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: A reverse transcription quantitative polymerase chain reaction study. Dev Neurosci 27 (2005) 408-418
44. Volpe J. Neurologic outcome of prematurity. Arch Neurol 55 (1998) 297-300
45. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50 (2001) 553-562
46. Williams C., Gunn A., Mallard C., and Gluckman P. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann Neurol 31 (1992) 14-21
47. Yong V., Power C., Forsyth P., and Edwards D. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2 (2001) 502-510
48. Zalewska T., Ziemka-Nalecz M., Sarnowska A., and Domanska-Janik K. Involvement of MMPs in delayed neuronal death after global ischemia. Acta Neurobiol Exp 62 (2002) 53-61
49. Zhang Y., Klassen H., Tucker B., Perez M., and Young M. CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism. J Neurosci 27 (2007) 4499-4506
50. Zuo J., Ferguson T., Hernandez Y., Stetler-Stevenson W., and Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18 (1998) 5203-5211